Immunopathology of the duodenal mucosa of HIV-positive patients during combined antiretroviral therapy

The objective of the present study was to evaluate the duodenal mucosa of HIV-infected patients during antiretroviral therapy. This was an observational study conducted on HIV-positive patients and a control group. Group 1 comprised 22 HIV-negative individuals while 38 HIV-positive individuals were classified according to the CDC 1993 classification into group 2 (A1 or A2) or group 3 (B2, A3, B3, C2, C3). All subjects were submitted to upper gastrointestinal endoscopy with duodenal biopsies. Qualitative, semi-quantitative and quantitative histological analyses were performed. Results were considered significant when P < 0.05. A higher prevalence of inflammatory infiltrate and eosinophilia was observed in the HIV group, together with a reduction in mucosal CD4+ lymphocyte (L) counts [median (lower-upper quartiles), 12.82 (8.30-20.33), 6.36 (1.75-11.66) and 1.75 (0.87-3.14) in groups 1, 2 and 3, respectively] which was not correlated with disease stage. The extent of CD4+L count reduction was similar in blood and duodenal mucosa. Normal CD8+L and CD45RO+L counts, and normal numbers of macrophages and antigen-presenting cells were also found in the HIV patients. The cytokine pattern did not differ among groups. Tissue HIV, assessed by p24 antigen, correlated with a higher CD45RO+L count (77.0 (61-79.8) and 43.6 (31.7-62.8) in p24+ and p24-, respectively, P = 0.003), and IL-4 positivity (100 and 48.2% in p24+ and p24-, respectively, P = 0.005). The duodenal mucosa of HIV+ patients showed a relatively preserved histological architecture. This finding may be characteristic of a population without opportunistic infections and treated with potent antiretroviral therapy, with a better preservation of the immune status.

Saved in:
Bibliographic Details
Main Authors: Machado,F.R., Pagliari,C., Caiafa,H., Tapajós,R., Duarte,M.I.S.
Format: Digital revista
Language:English
Published: Associação Brasileira de Divulgação Científica 2006
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2006000100013
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S0100-879X2006000100013
record_format ojs
spelling oai:scielo:S0100-879X20060001000132005-12-15Immunopathology of the duodenal mucosa of HIV-positive patients during combined antiretroviral therapyMachado,F.R.Pagliari,C.Caiafa,H.Tapajós,R.Duarte,M.I.S. Intestinal histopathology Cytokines Human immunodeficiency virus Acquired immunodeficiency syndrome Antiretroviral therapy CD4+ The objective of the present study was to evaluate the duodenal mucosa of HIV-infected patients during antiretroviral therapy. This was an observational study conducted on HIV-positive patients and a control group. Group 1 comprised 22 HIV-negative individuals while 38 HIV-positive individuals were classified according to the CDC 1993 classification into group 2 (A1 or A2) or group 3 (B2, A3, B3, C2, C3). All subjects were submitted to upper gastrointestinal endoscopy with duodenal biopsies. Qualitative, semi-quantitative and quantitative histological analyses were performed. Results were considered significant when P < 0.05. A higher prevalence of inflammatory infiltrate and eosinophilia was observed in the HIV group, together with a reduction in mucosal CD4+ lymphocyte (L) counts [median (lower-upper quartiles), 12.82 (8.30-20.33), 6.36 (1.75-11.66) and 1.75 (0.87-3.14) in groups 1, 2 and 3, respectively] which was not correlated with disease stage. The extent of CD4+L count reduction was similar in blood and duodenal mucosa. Normal CD8+L and CD45RO+L counts, and normal numbers of macrophages and antigen-presenting cells were also found in the HIV patients. The cytokine pattern did not differ among groups. Tissue HIV, assessed by p24 antigen, correlated with a higher CD45RO+L count (77.0 (61-79.8) and 43.6 (31.7-62.8) in p24+ and p24-, respectively, P = 0.003), and IL-4 positivity (100 and 48.2% in p24+ and p24-, respectively, P = 0.005). The duodenal mucosa of HIV+ patients showed a relatively preserved histological architecture. This finding may be characteristic of a population without opportunistic infections and treated with potent antiretroviral therapy, with a better preservation of the immune status.info:eu-repo/semantics/openAccessAssociação Brasileira de Divulgação CientíficaBrazilian Journal of Medical and Biological Research v.39 n.1 20062006-01-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2006000100013en10.1590/S0100-879X2006000100013
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Machado,F.R.
Pagliari,C.
Caiafa,H.
Tapajós,R.
Duarte,M.I.S.
spellingShingle Machado,F.R.
Pagliari,C.
Caiafa,H.
Tapajós,R.
Duarte,M.I.S.
Immunopathology of the duodenal mucosa of HIV-positive patients during combined antiretroviral therapy
author_facet Machado,F.R.
Pagliari,C.
Caiafa,H.
Tapajós,R.
Duarte,M.I.S.
author_sort Machado,F.R.
title Immunopathology of the duodenal mucosa of HIV-positive patients during combined antiretroviral therapy
title_short Immunopathology of the duodenal mucosa of HIV-positive patients during combined antiretroviral therapy
title_full Immunopathology of the duodenal mucosa of HIV-positive patients during combined antiretroviral therapy
title_fullStr Immunopathology of the duodenal mucosa of HIV-positive patients during combined antiretroviral therapy
title_full_unstemmed Immunopathology of the duodenal mucosa of HIV-positive patients during combined antiretroviral therapy
title_sort immunopathology of the duodenal mucosa of hiv-positive patients during combined antiretroviral therapy
description The objective of the present study was to evaluate the duodenal mucosa of HIV-infected patients during antiretroviral therapy. This was an observational study conducted on HIV-positive patients and a control group. Group 1 comprised 22 HIV-negative individuals while 38 HIV-positive individuals were classified according to the CDC 1993 classification into group 2 (A1 or A2) or group 3 (B2, A3, B3, C2, C3). All subjects were submitted to upper gastrointestinal endoscopy with duodenal biopsies. Qualitative, semi-quantitative and quantitative histological analyses were performed. Results were considered significant when P < 0.05. A higher prevalence of inflammatory infiltrate and eosinophilia was observed in the HIV group, together with a reduction in mucosal CD4+ lymphocyte (L) counts [median (lower-upper quartiles), 12.82 (8.30-20.33), 6.36 (1.75-11.66) and 1.75 (0.87-3.14) in groups 1, 2 and 3, respectively] which was not correlated with disease stage. The extent of CD4+L count reduction was similar in blood and duodenal mucosa. Normal CD8+L and CD45RO+L counts, and normal numbers of macrophages and antigen-presenting cells were also found in the HIV patients. The cytokine pattern did not differ among groups. Tissue HIV, assessed by p24 antigen, correlated with a higher CD45RO+L count (77.0 (61-79.8) and 43.6 (31.7-62.8) in p24+ and p24-, respectively, P = 0.003), and IL-4 positivity (100 and 48.2% in p24+ and p24-, respectively, P = 0.005). The duodenal mucosa of HIV+ patients showed a relatively preserved histological architecture. This finding may be characteristic of a population without opportunistic infections and treated with potent antiretroviral therapy, with a better preservation of the immune status.
publisher Associação Brasileira de Divulgação Científica
publishDate 2006
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2006000100013
work_keys_str_mv AT machadofr immunopathologyoftheduodenalmucosaofhivpositivepatientsduringcombinedantiretroviraltherapy
AT pagliaric immunopathologyoftheduodenalmucosaofhivpositivepatientsduringcombinedantiretroviraltherapy
AT caiafah immunopathologyoftheduodenalmucosaofhivpositivepatientsduringcombinedantiretroviraltherapy
AT tapajosr immunopathologyoftheduodenalmucosaofhivpositivepatientsduringcombinedantiretroviraltherapy
AT duartemis immunopathologyoftheduodenalmucosaofhivpositivepatientsduringcombinedantiretroviraltherapy
_version_ 1756391133611556864